van Hall T - Search Results

1

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein.

Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R. Medema JP, et al. Among authors: van hall t. J Exp Med. 1999 Oct 4;190(7):1033-8. doi: 10.1084/jem.190.7.1033. J Exp Med. 1999. PMID: 10510093 Free PMC article.

2

The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent.

Middelburg J, Ghaffari S, Schoufour TAW, Sluijter M, Schaap G, Göynük B, Sala BM, Al-Tamimi L, Scheeren F, Franken KLMC, Akkermans JJLL, Cabukusta B, Joosten SA, Derksen I, Neefjes J, van der Burg SH, Achour A, Wijdeven RHM, Weidanz J, van Hall T. Middelburg J, et al. Among authors: van hall t. Cell Rep. 2023 Dec 26;42(12):113516. doi: 10.1016/j.celrep.2023.113516. Epub 2023 Dec 3. Cell Rep. 2023. PMID: 38048225 Free article.

3

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

van Gulijk M, van Krimpen A, Schetters S, Eterman M, van Elsas M, Mankor J, Klaase L, de Bruijn M, van Nimwegen M, van Tienhoven T, van Ijcken W, Boon L, van der Schoot J, Verdoes M, Scheeren F, van der Burg SH, Lambrecht BN, Stadhouders R, Dammeijer F, Aerts J, van Hall T. van Gulijk M, et al. Among authors: van hall t. Sci Immunol. 2023 May 19;8(83):eabn6173. doi: 10.1126/sciimmunol.abn6173. Epub 2023 May 19. Sci Immunol. 2023. PMID: 37205768

4

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

Vierboom MP, Nijman HW, Offringa R, van der Voort EI, van Hall T, van den Broek L, Fleuren GJ, Kenemans P, Kast WM, Melief CJ. Vierboom MP, et al. Among authors: van den broek l, van hall t, van der voort ei. J Exp Med. 1997 Aug 29;186(5):695-704. doi: 10.1084/jem.186.5.695. J Exp Med. 1997. PMID: 9271585 Free PMC article.

5

Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes.

van Hall T, van de Rhee NE, Schoenberger SP, Vierboom MP, Verreck FA, Melief CJ, Offringa R. van Hall T, et al. Among authors: van de rhee ne. Cancer Res. 1998 Jul 15;58(14):3087-93. Cancer Res. 1998. PMID: 9679975

6

Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.

Beekman NJ, van Veelen PA, van Hall T, Neisig A, Sijts A, Camps M, Kloetzel PM, Neefjes JJ, Melief CJ, Ossendorp F. Beekman NJ, et al. Among authors: van hall t, van veelen pa. J Immunol. 2000 Feb 15;164(4):1898-905. doi: 10.4049/jimmunol.164.4.1898. J Immunol. 2000. PMID: 10657639

7

Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.

van Hall T, van Bergen J, van Veelen PA, Kraakman M, Heukamp LC, Koning F, Melief CJ, Ossendorp F, Offringa R. van Hall T, et al. Among authors: van veelen pa, van bergen j. J Immunol. 2000 Jul 15;165(2):869-77. doi: 10.4049/jimmunol.165.2.869. J Immunol. 2000. PMID: 10878361

8

Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.

Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van Hall T, Offringa R, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: van hall t. Cancer Res. 2000 Dec 15;60(24):6995-7001. Cancer Res. 2000. PMID: 11156402

9

Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.

Heukamp LC, van Hall T, Ossendorp F, Burchell JM, Melief CJ, Taylor-Papadimitriou J, Offringa R. Heukamp LC, et al. Among authors: van hall t. J Immunother. 2002 Jan-Feb;25(1):46-56. doi: 10.1097/00002371-200201000-00005. J Immunother. 2002. PMID: 11926165

10

Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines.

Wiegant J, van Hall T, van der Burg M, Colombo M, Tanke HJ, Offringa R, Rosenberg C. Wiegant J, et al. Among authors: van hall t, van der burg m. Cancer Genet Cytogenet. 2002 Dec;139(2):126-32. doi: 10.1016/s0165-4608(02)00623-4. Cancer Genet Cytogenet. 2002. PMID: 12550772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters